top
Search terms
Results 1 - 10 of 35 - ordered by :
Pages: 1 2 3 4
Heart

Martin R Cowie Correspondence to Professor Martin R Cowie, National Heart & Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK; m.cowie{at}imperial.ac.uk Received 6 January ...

Heart, Editorial, Martin R Cowie

Date : 15/05/2016
Heart

Sudden death is a known but unpredictable complication of hypertrophic cardiomyopathy. Arrhythmia complicating pre-excitation appears to be one of the factors responsible for sudden death in ...

British Heart Journal, Research Article, D M Krikler, M J Davies, E Rowland, J F Goodwin, R C Evans, D B Shaw

Date : 01/03/1980
Epeuropace

Ventricular fibrillation was the cause of appropriate ICD shocks in half the cases and fractional shortening (as a measure of left ventricular systolic function) was the only independent predictor ...

Europace, Editorial, Michelle Michels

Date : 01/05/2012 Item size : 134185 bytes
Epeuropace

A 30-year-old woman with hypertrophic cardiomyopathy had received a subcutaneous-only implantable cardioverter defibrillator (S-ICD) before for secondary prevention of sudden cardiac ...

Europace, CASE EXPRESS REPORTS, Alexander H. Maass, Isabelle C. Van Gelder

Date : 01/07/2014 Item size : 99466 bytes
Epeuropace

Abstract Aims The aim of this study was to describe the early phase United Kingdom (UK) clinical experience with a novel entirely subcutaneous implantable cardioverter-defibrillator ...

Europace, Sudden death and ICDs, Julian W. E. Jarman, Derick M. Todd

Date : 01/08/2013
Epeuropace

Abstract A paediatric patient with hypertrophic cardiomyopathy (HCM) presented cardiac arrest due to ventricular fibrillation. The risk factors and the potential mechanism leading to recurrent ...

Europace, ELECTROPHYSIOLOGY IN MYOPATHIES, Alonso Pedrote, Francisco J. Morales, Lorena García-Riesco, Francisco Errazquin

Date : 01/06/2006
Epeuropace

Is the coexistence of sustained ST-segment elevation and abnormal Q waves a risk factor for electrical storm in implanted cardioverter defibrillator patients with structural heart diseases? Abstract ...

Europace, CLINICAL RESEARCH, Hiroshi Furushima, Masaomi Chinushi, Kenichi Iijima, Kanae Hasegawa, Akinori Sato, Daisuke Izumi, Hiroshi Watanabe, Yoshifusa Aizawa

Date : 01/05/2012
Epeuropace

Methods and results All women in routine follow-up at our institution for ICD implantation who became pregnant between 2006 and 2013 were included in this study. Introduction In recent years, the ...

Europace, CLINICAL RESEARCH, Stéphane Boulé, Lionel Ovart, Christelle Marquié, Edward Botcherby, Didier Klug, Claude Kouakam, François Brigadeau, Laurence Guédon-Moreau, Ludivine ...

Date : 01/11/2014
Epeuropace

Long-term follow-up of children and young adults treated with implantable cardioverter-defibrillator: the authors' own experience with optimal implantable cardioverter-defibrillator ...

Europace, Implantable Cardioverter-Defibrillators, Michał Lewandowski, Maciej Sterliński, Aleksander Maciąg, Paweł Syska, Ilona Kowalik, Hanna Szwed, Lidia Chojnowska, Andrzej Przybylski

Date : 01/09/2010
Ehjcardiovascrec

KeywordsArrhythmia (mechanisms)CardiomyopathySudden deathVentricular arrhythmiasTime for primary review 25 days. 1 Introduction The prediction of sudden arrhythmic death (SCD) in patients with ...

Cardiovascular Research, Review, R.C. Saumarez, A.A. Grace

Date : 01/07/2000